6
Tokyo-headquartered Elix and the Graduate School of Life Sciences at Tohoku University signed a joint research agreement aimed at advancing drug discovery using AI technologies.
Company officials say Elix is an AI drug discovery company with the mission of “Rethinking Drug Discovery.” To reduce the immense costs and time associated with drug development while enhancing success rates, Elix reports that it leverages AI and machine learning in collaborations with pharmaceutical companies, universities, research institutes,…